Finance

Lists
MD:NYSE
Pediatrix Medical Group Inc
$25.76
+0.12%
(+0.030) 1D
$25.76
0.00% (0.00)
After hours
Closed: Oct 1, 4:00:03 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MD...
Open
$25.80
High
$26.12
Low
$25.40
Mkt. cap
2.09B
Avg. vol.
735.31K
Volume
1.53M
P/E ratio
12.37
52-wk high
$27.94
52-wk low
$15.70
EPS
$2.08
Beta
0.64
Shares outstanding
81.25M
No. of employees
4K
Open
$25.80
High
$26.12
Low
$25.40
Mkt. cap
2.09B
Avg. vol.
735.31K
Volume
1.53M
P/E ratio
12.37
52-wk high
$27.94
52-wk low
$15.70
EPS
$2.08
Beta
0.64
Shares outstanding
81.25M
No. of employees
4K
News stories
From web sources and news partners
About Pediatrix Medical Group Inc
CEOJames D. Swift
Employees4.28K
Founded2007
Headquarters-
SectorHealth care provider
Websitepediatrix.com
Analyst ratings
Based on 6 analysts giving stock ratings to MD in the past 3 months
Hold
Buy
1
Hold
5
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for MD in the last 3 months.
Highest
Current $25.76
$28.00 (+8.70%)
Average
$27.40 (+6.37%)
Lowest
$25.00 (-2.95%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jack Slevin
Jefferies
Hold
Downgraded
$28.00
+8.7%
08/19/2026
Ann Hynes
Mizuho Securities
Hold
Maintained
$28.00
+8.7%
08/11/2026
A.J. Rice
UBS
Hold
Maintained
$28.00
+8.7%
08/06/2026
David S Macdonald
Truist Financial
Hold
Maintained
$28.00
+8.7%
08/05/2026
Pito Chickering
Deutsche Bank
Hold
Reiterated
$25.00
-3%
08/05/2026
Ryan Daniels
William Blair
Buy
Maintained
-
-
08/04/2026
Unknown Analyst
Mizuho Securities
Hold
Maintained
-
-
02/20/2026
Last report
Aug 4, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.63 / $0.59
+6.60%beat
Revenue / Est. (USD)
487.78M / 478.00M
+2.05%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
492.88M
493.77M
476.20M
487.78M
Cost of goods sold
352.53M
367.79M
363.23M
355.31M
Cost of revenue
352.53M
367.79M
363.23M
355.31M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
60.79M
65.68M
60.27M
61.29M
Operating expense
66.34M
71.31M
66.38M
67.07M
Total operating expenses
418.87M
439.10M
429.62M
422.39M
Operating income
74.00M
54.67M
46.58M
65.40M
Other non operating income
-
-
-
-
EBT including unusual items
87.78M
45.60M
38.84M
54.00M
EBT excluding unusual items
72.83M
51.47M
43.77M
62.48M
Income tax expense
16.07M
11.91M
9.27M
14.16M
Effective tax rate
18.31%
26.13%
23.87%
26.22%
Other operating expenses
-
-
-
-
Net income
71.71M
33.68M
29.57M
39.84M
Net profit margin
14.55%
6.82%
6.21%
8.17%
Earnings per share
0.67
0.50
0.44
0.63
Interest and investment income
5.88M
4.70M
4.76M
4.55M
Interest expense
-8.94M
-8.74M
-8.26M
-8.17M
Net interest expenses
-3.06M
-4.04M
-3.50M
-3.62M
Depreciation and amortization charges
5.55M
5.63M
6.12M
5.78M
EBITDA
79.56M
60.30M
52.70M
71.18M
Gain or loss from assets sale
-20.91M
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps